Proteolix

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Proteomics

This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.

Protego Biopharma

This biotechnology company develops small molecule therapies for patients with systemic amyloid diseases and other protein misfolding disorders.

Peloton Therapeutics

This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.

Apexian Pharmaceuticals

This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.

Plexium

This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.